Search research articles
Contact Us
Filters
Showing results (1-10 of 80) with videos related to
Page
of 8
Sort By:
Clinical Microbiology Reviews
|
October 23, 1997
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
H F Chambers
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 10, 2006
Ceftobiprole: in-vivo profile of a bactericidal cephalosporin
H F Chambers
Clinical Microbiology Reviews
|
April 1, 1988
Methicillin-resistant staphylococci
H F Chambers
Antimicrobial Agents and Chemotherapy
|
December 1, 1987
Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a
H F Chambers
The Journal of Infectious Diseases
|
March 19, 1999
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
H F Chambers
Infectious Disease Clinics of North America
|
June 1, 1993
Detection of methicillin-resistant staphylococci
H F Chambers
The Journal of Antimicrobial Chemotherapy
|
July 1, 1992
Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus
H F Chambers
Antimicrobial Agents and Chemotherapy
|
February 1, 1995
In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a
H F Chambers
Infection Control and Hospital Epidemiology
|
January 1, 1991
Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus
H F Chambers
Emerging Infectious Diseases
|
April 11, 2001
The changing epidemiology of Staphylococcus aureus?
H F Chambers
Page
of 8
Search research articles
Search
Showing results (1-10 of 80) with videos related to
Sort By:
Page
of 8
Clinical Microbiology Reviews
|
October 23, 1997
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
H F Chambers
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 10, 2006
Ceftobiprole: in-vivo profile of a bactericidal cephalosporin
H F Chambers
Clinical Microbiology Reviews
|
April 1, 1988
Methicillin-resistant staphylococci
H F Chambers
Antimicrobial Agents and Chemotherapy
|
December 1, 1987
Coagulase-negative staphylococci resistant to beta-lactam antibiotics in vivo produce penicillin-binding protein 2a
H F Chambers
The Journal of Infectious Diseases
|
March 19, 1999
Penicillin-binding protein-mediated resistance in pneumococci and staphylococci
H F Chambers
Infectious Disease Clinics of North America
|
June 1, 1993
Detection of methicillin-resistant staphylococci
H F Chambers
The Journal of Antimicrobial Chemotherapy
|
July 1, 1992
Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus
H F Chambers
Antimicrobial Agents and Chemotherapy
|
February 1, 1995
In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a
H F Chambers
Infection Control and Hospital Epidemiology
|
January 1, 1991
Treatment of infection and colonization caused by methicillin-resistant Staphylococcus aureus
H F Chambers
Emerging Infectious Diseases
|
April 11, 2001
The changing epidemiology of Staphylococcus aureus?
H F Chambers
Page
of 8